Our final Leader Forum of the year, hosted by Joanne Tordoff, VP of Medical Solutions, was a powerful session on "Embracing our Global Organization." With Amplity’s presence spanning 6 continents, we explored cultural sensitivity and professional awareness, emphasizing the importance of a considerate global mindset—even for leaders without internationally-based teams. The session showcased our commitment to leadership development and included some fun moments too! Thank you to everyone who joined and helped make it a success! Want to join Team Amplity? Visit our Careers page: https://lnkd.in/gtnqe7J9
This month, we’re celebrating incredible journeys at Amplity as our team members hit major milestones: 🌟 5 Years of Excellence: Eugene Vais, Product Support Vice President John Perez, Director, Insights Operation Joseph Turner, Head of Insights Toni Jauset, Field Manager Wendy Haggerty, Biosimilar Account Specialist 🎉 A Decade of Impact: Jillian DiSabatino, Sales Representative Pooja Patel, Regional Sales Consultant From 5 years of contributions to 10 years of dedication, your work inspires us all. Thank you for your passion and for being part of Amplity’s story!
What makes a workplace special? For Tim Schlosser, it’s Amplity's dedication to patients, ethics + our client partners. View our EPIIC Values: https://www.amplity.com/about-amplity
Proud to support our pharma + biotech client partners at hashtag#SABCS24! The key Day 2 insights driving the conversation include: 1. Navigators are playing an increasingly important role, and biopharma companies must prioritize meaningful engagement with them to have an impact with patients. 2. The breast cancer clinical trial landscape is highly competitive. Success depends on having pharma innovate + expand site selection strategies. 3. There’s an urgent need for greater efforts to engage underserved + underrepresented populations in clinical trials, ensuring more equitable access to groundbreaking treatments. Connect with us onsite to explore how we can support your breast cancer and broader oncology initiatives.
Our compliance gurus, Keysha Bradford + Erin Reede, M.Ed, MS HRD, CCEP, recently attended The 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress in DC! This incredible event brought together 800+ compliance professionals to share practical strategies for managing risk + advancing patient care. A key theme — not surprisingly — was the transformative power of AI. The takeaway? Pharma companies must understand their data sources + analyze risks effectively to enhance compliance programs, optimize resource allocation + drive better patient outcomes. Learn more about our award-winning AI offerings now. https://lnkd.in/gjxrpzp5
At Amplity, we’re proud to support a culture of giving back, and today, on International Volunteer Day, we’re spotlighting five team members whose compassion and dedication inspire us all. Their stories below highlight the power of service and the extraordinary impact our team has around the globe. Team Amplity, thank you for driving positive change—not just through the work we do every day but also through your generosity and dedication to your communities.
Oncology practice managers, we've built a community just for you. For readers of Oncology Practice Management, please join us on our new, dedicated LinkedIn page: https://lnkd.in/ef8fXh2x Oncology Practice Management (OPM) seeks to offer process solutions for the ever-changing business of oncology to members of the cancer care team, including medical, surgical, and radiation oncologists, as well as executives, practice administrators, financial counselors, and billers/coders.
Thanks for your expertise Denise Chambley, PharmD, Amplity's Head of Global Medical Solutions, for sharing a view in a recent Precision Medicine Online story. "After Success in Treating Cancer, Car T-Cells Break Into AutoImmune, HIV, and More" was written by Jessica Kim Cohen and published on Nov. 15, 2024. Speaking about the potential market for CAR T-cell therapies beyond cancer treatment, Denise observed that if CAR T-cell therapies can prove their efficacy and ability to provide long-term remission for autoimmune diseases, market access decisions will have to consider a larger, younger, and potentially healthier population that could benefit from these therapies. The quote was presented within the context of the pharmacoeconomics of CAR T-cell therapies for non-cancer treatment.
Let’s celebrate our incredible team members who are marking 5 amazing years with Amplity! David Dusenbery, Systems Administrator Keysha Bradford, Vice President, Compliance Michael Faulkner, Customer Care Supervisor Suhail Haque, Medical Science Liaison Your hard work, dedication, and passion continue to make a lasting impact. Thank you for everything you do. Here’s to the next chapter!
Pharma market access and brand marketing leaders, pleased to share our latest publication: ImPACT Federal Health. ImPACT Federal Health will provide best practices, discussion forums, and the latest clinical news to help physicians, pharmacists, nurse practitioners, and physician assistants in federal healthcare overcome medical and commercial challenges to deliver best-in-class care to our nation’s heroes and their families. If you'd like to get in front of this critical audience caring for our nation's heroes, please reach out to Lea D.. Learn more: https://bit.ly/48MtkSt
